CureVac (NASDAQ:CVAC) | Finanzwire

Basculer en Français

8606	Companies
141230	Keywords
77160	Articles
75477	Press releases

Home
Companies
CureVac

BRIEF

published on 04/08/2025 at 13:05, 1 day 7 hours ago

CureVac Announces Financial Results and Business Update for 2024

Financial Results Conference Call Business Update MRNA Technology CureVac
PRESS RELEASE

published on 04/08/2025 at 13:00, 1 day 7 hours ago

CureVac to Report Fourth Quarter and Full-Year 2024 Financial Results and Business Update on April 10, 2025
CureVac to Report Fourth Quarter and Full-Year 2024 Financial Results and Business Update on April 10, 2025. Conference call and webcast scheduled at 3 p.m. CET / 9 a.m. EST

Financial Results Conference Call Business Update MRNA Technology CureVac
BRIEF

published on 04/07/2025 at 13:05, 2 days 7 hours ago

CureVac Advances mRNA Immunotherapy for Lung Cancer

FDA Clearance Clinical Trial CureVac MRNA Immunotherapy SqNSCLC
PRESS RELEASE

published on 04/07/2025 at 13:00, 2 days 7 hours ago

CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer
CureVac receives U.S. FDA clearance for phase 1 trial of mRNA immunotherapy in squamous NSCLC, a novel approach combining precision therapy with pembrolizumab

FDA Clearance CureVac MRNA Immunotherapy Squamous NSCLC Precision Therapy
BRIEF

published on 03/27/2025 at 21:10, 12 days 23 hours ago

CureVac Secures Patent Win Against BioNTech

BioNTech MRNA Technology CureVac Patent Litigation European Patent Office
PRESS RELEASE

published on 03/27/2025 at 21:05, 12 days 23 hours ago

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE
CureVac receives positive validity decision from European Patent Office in litigation against BioNTech SE regarding mRNA patent

BioNTech SE CureVac Patent Litigation European Patent Office MRNA Patent
BRIEF

published on 02/18/2025 at 13:08, 1 month 19 days ago

CureVac Recognized as a Global Innovator by LexisNexis

MRNA Technology Patent Portfolio CureVac Health Innovation Top Innovator
PRESS RELEASE

published on 02/18/2025 at 13:03, 1 month 19 days ago

CureVac Earns Repeat Recognition by LexisNexis® as One of the World’s Top Innovators
CureVac recognized as Top 100 Global Innovator by LexisNexis for third year in a row due to its extensive mRNA technology patent portfolio. Company leads in mRNA science

MRNA Technology Patent Portfolio CureVac Global Innovator LexisNexis
BRIEF

published on 11/12/2024 at 13:05, 4 months 27 days ago

CureVac Reports Q3 Financial Results and Business Updates for 2024

Financial Results MRNA Technology Strategic Restructuring GSK Collaboration Oncology Development
PRESS RELEASE

published on 11/12/2024 at 13:00, 4 months 27 days ago

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update
CureVac announces financial results for the third quarter of 2024, including strengthened cash position, new oncology and prophylactic vaccine programs, workforce reduction, and new CFO appointment

Financial Results Oncology CureVac Prophylactic Vaccines Workforce Reduction

1 2 ... 8

Accesswire

Published on 04/09/2025 at 20:10, 39 minutes ago

Taranis Quantifies Hydrothermal Alteration System at Thor to Improve Targeting for 2025 Deep Exploration Drilling
Published on 04/09/2025 at 18:00, 2 hours 49 minutes ago

BrooQLy Inc. (BRQL) dba Dynamic Aerospace Systems Appoints FedEx Leader in Logistics to Board of Directors
Published on 04/09/2025 at 15:15, 5 hours 34 minutes ago

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 04/09/2025 at 15:00, 5 hours 49 minutes ago

The Cree Trappers Association, the Cree Hunters Economic Security Board and Mining & Exploration Companies Approve 2025 Funding to Continue the Reconstruction of Cabins Burnt During the 2023 Forest Fires, James Bay, Quebec
Published on 04/09/2025 at 15:00, 5 hours 49 minutes ago

The Cree Trappers Association, the Cree Hunters Economic Security Board and Mining & Exploration Companies Approve 2025 Funding to Continue the Reconstruction of Cabins Burnt during the 2023 Forest Fires, James Bay, Quebec

View all ACCESSWIRE

EQS Group

Published on 04/09/2025 at 20:20, 29 minutes ago

Zimbabwe Government Delivers on Commitment: Compensation of Former Farm Owners under the Global Compensation Deed Commences
Published on 04/09/2025 at 20:18, 31 minutes ago

EQS-Adhoc: VOLKSWAGEN AKTIENGESELLSCHAFT: Volkswagen AG publishes preliminary key figures for the financial statements as of March 31, 2025
Published on 04/09/2025 at 19:08, 1 hour 40 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/09/2025 at 18:34, 2 hours 14 minutes ago

PolyPeptide announces results of the annual General Meeting 2025
Published on 04/09/2025 at 18:02, 2 hours 46 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares

Les Echos

Published on 04/09/2025 at 18:59, 1 hour 49 minutes ago

Description of the 2025-2026 Share Buyback Program
Published on 04/09/2025 at 18:57, 1 hour 51 minutes ago

Minutes of the Combined General Meeting held on April 9, 2025
Published on 04/09/2025 at 17:45, 3 hours 4 minutes ago

COGELEC : 2024 full-year results and Q1 2025 revenue.
Published on 04/09/2025 at 17:40, 3 hours 9 minutes ago

COGELEC : Statement on the total number of shares and voting rights.
Published on 04/09/2025 at 08:00, 12 hours 49 minutes ago

Museum Studio becomes a majority shareholder in Lord Cultural Resources

View all LES ECHOS COMFI WIRE